REG - Substrate Artificial Substrate AI-Class B - Delist from the AQSE, to remain listed on BME

Substrate Artificial Inteligence SAAnnouncement

18/10/2024 17:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241018:nRSR7992Ia&default-theme=true

RNS Number : 7992I  Substrate Artificial Inteligence,SA  18 October 2024

 

 

 

 

18 October 2024

 

 

SUBSTRATE ARTIFICIAL INTELIGENCE SOCIEDAD ANONIMA

("Substrate AI" or the "Company")

 

Substrate to Delist from the AQSE Growth Market, Remains Listed on BME Growth
Market

 

 

 

Substrate AI (AQUIS: SAI/SAI.B) announces its intention to withdraw both the
Company's ordinary shares (class A shares) and the preference shares (class B
shares) (together the "Shares") from trading on the AQSE Growth Market
("AQSE").

Pursuant to the AQSE Access Rulebook, the Company is required to give 20
business days' notice of its intention to withdraw from trading on AQSE.
Therefore, trading in the Shares will cease at 7:00 am UK time on 15 November
2024.

The Company's Shares will continue to trade on the BME growth Market in Spain
under "SAI" and "SAI.B".

The Directors of Substrate AI accept responsibility for this announcement.

 Substrate AI
 Lorenzo Serratosa                     info@substrate.ai (mailto:info@substrate.ai)

 Chairman
 First Sentinel Corporate Finance

 Corporate Advisors
 Brian Stockbridge                     +44 (0) 7858 888 007

 

This announcement contains information which, prior to its disclosure, was
inside information as stipulated under Regulation 11 of the Market Abuse
(Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication
of this announcement via a Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXBVLFFZBLLFBK